Portfolios

Cutting-edge research towards the clinical application of iPS cells

Research using iPS cells will bring about breakthrough changes in the future of medicine including the research and development of new drugs, cell therapies and drug safety evaluation processes. At Takeda's Shonan Health Innovation Park, T-CiRA is conducting cutting-edge research towards the clinical application of iPS cells to cure rare, intractable diseases that currently have no established effective treatments.

Main Areas of Research

• Research towards the clinical application of iPS cells for neuro-psychiatric disorders, cancer, intractable muscle diseases, and gastrointestinal diseases etc.
• Research to develop medicines and cell therapies using iPS cells.